Breakthrough Study Uncovers ‘Off Switch’ for COVID mRNA Shots
Mercola | 1 July 2024 A preprint study led by Dr. Peter McCullough suggests using siRNA and RIBOTACs to target and degrade residual mRNA from COVID-19 vaccines, potentially mitigating long-term health risks associated with persistent spike protein production COVID-19 mRNA vaccines have shown wider distribution in the body than initially claimed, raising concerns about unintended effects and the need for an “off switch” to stop ongoing spike protein production The study proposes using siRNA and RIBOTACsRead More→